Download centre
Order free copy of Form 20-F
Please click here to subscribe to Reports and SMS notifications
Conference calls
LEAD 3 liraglutide phase 3 conference call | Listen to the conference call on 11 December 2007 (17.00 pm CET) | ENG |
Liraglutide obesity phase 2 conference call | Listen to the conference call on 20 November 2007 (15.00 pm. CET) | ENG |
Webcast Q3 2007 - London | Listen to the webcast | ENG |
Q3 results 2007 | Listen to the conference call on 31 October 2007 (13.00 CET) | ENG |
Q2 results 2007 | Listen to the conference call on 3 August 2007 (13.00 CET) | ENG |
Liraglutide phase 3, Lead 5 Conference Call | Listen to the conference call on 21 June 2007 (12.30 pm. CET) | ENG |
Q1 results 2007 | Listen to the conference call on 2 May 2007 (13.00 CET) | ENG |
ICH Phase 3 Conference Call | Listen to the conference call on 26 February 2007 (10.00 CET) | ENG |
Full year results 2006 | Listen to the conference call on 31 January 2007 (13.00 CET) | ENG |
Annual reviews
Novo Nordisk Proxy Mailing | Description of the Novo Nordisk Proxy Mailing | ENG |
Novo Nordisk A/S 401K Plan | Vote document | ENG |
ADR proxy common | Vote document | ENG |
Advertisement | The advertisment in danish | DA |
AGM minutes | The minutes from the AGM 2007 | ENG |
Articles of associations | AGM 2007 | ENG DA |
Copenhagen Stock Exchange | Danish Corporate Governance Recommendations (2005) | ENG |
Notice of AGM | AGM 2007 | DA ENG |
Ordering of admission card | AGM 2007 | ENG DA |
Consolidated financial statements | Management‘s remuneration, share options and shareholdings | ENG |
Annual reports
Shareholder magazine
Interim reports
IR presentations
LEAD 3 liraglutide phase 3 conference call slides | 11 December 2007 | ENG |
Liraglutide obesity phase 2 conference call slides | 20 November 2007 | ENG |
Investor Presentation November 2007 | 5 November - London: First nine months of 2007, roadshow at Merrill Lynch | ENG |
Investor Presentation October 2007 | 31 October - Copenhagen: First nine months of 2007, roadshow at Handelsbanken | ENG |
Teleconference / Q3 - 31 October 2007 | Download slides (pdf) | ENG |
Investor Presentation September 2007 | UBS Global Life Sciences Conference, New York, 24 September 2007 | ENG |
Investor Presentation September 2007 | Carnegie Danish Large Cap, Copenhagen, 24 September 2007 | ENG |
Investor Presentation September 2007 | Merrill Lynch, Global Pharmaceutical, Biotech & Medtech Conference, London, 20 September 2007 | ENG |
Investor Presentation September 2007 | Bear Stearns Healthcare Conference, New York, 10 September 2007 | ENG |
Investor Presentation September 2007 | 2nd European Healthcare Investors Conference, Oppenheim Research GMBH, Frankfurt, 4 September 2007 | ENG |
Investor Presentation August 2007 | 30-31 August - Tokyo: First six months of 2007 roadshow with Morgan Stanley | ENG |
Investor Presentation August 2007 | 6 August - London: First six months of 2007 roadshow at Morgan Stanley | ENG |
Investor Presentation August 2007 | 3 August - Copenhagen: First six months of 2007 roadshow at SEB Enskilda | ENG |
Teleconference / Q2 - 3 August 2007 | Download slides (Pdf) | ENG |
Liraglutide phase 3, Lead 5 Conference Call slides | 21 June 2007 | ENG |
Investor Presentation May 2007 | OMX / Enskilda Nordic Seminar, New York 17 May 2007 | ENG |
Investor Presentation May 2007 | Citigroups Healtcare Conference, New York 22 May 2007 | ENG |
Investor Presentation May 2007 | Carnegie Nordic Health Care Seminar, Stockholm 30 May 2007 | ENG |
Investor Presentation May 2007 | 3 May - London: First three months of 2007 roadshow at Deutsche Bank | ENG |
Investor Presentation May 2007 | 2 May - Copenhagen: First three months of 2007 roadshow at Danske Bank | ENG |
Teleconference / Q1 - 2 May 2007 | Download slides (Pdf) | ENG |
Spring European Large Cap Conference | Cheuvreux, Paris 30 March 2007 | ENG |
Lehman Brothers Global Heathcare Conference | Miami, 20 March 2007 | ENG |
Carnegie Nordic Large Cap | Stockholm, 6 March 2007 | ENG |
Bear Stearns London Healthcare Conference | 27 February 2007 | ENG |
ICH Phase 3 Conference Call slides | 26 February 2007 | ENG |
Investor presentation February 2007 | 07 February - New York: Full Year 2006 roadshow at Merrill Lynch conference | ENG |
Investor Presentation February 2007 | 01 February - London: Full Year 2006 roadshow at Bear Stearns | ENG |
Investor Presentation January 2007 | 31 January - Copenhagen: Full Year 2006 roadshow at Carnegie | ENG |
Teleconference FY 2006 - 31 January 2007 | Download slides (Pdf) | ENG |
Investor day 2007: Global biologics manufacturing
Web cast from Investor Day 2007 | Web cast from Global Biologics Manufacturing | ENG |
Welcome | Welcome by Jesper Brandgaard, CFO | ENG |
Global production strategy | Global production strategy by Per Valstorp, Product Supply | ENG |
Upstream manufacturing | Upstream manufacturing by Jesper Giede Bøving, Diabetes API | ENG |
Downstream manufacturing | Downstream manufacturing by Kim Tosti, SVP, Diabetes Finished Products | ENG |
Device manufacturing | Device manufacturing by Jesper Kløve, SVP, Devices and Sourcing | ENG |
Regulatory requirements | Regulatory requirements by Peter Bonne Eriksen, SVP, Regulatory Affairs | ENG |
Concluding remarks | Concluding remarks by Jesper Brandgaard, CFO | ENG |
SEC filings (Form 20-F)
Form 20 2007 | Shareholders and ADR holders may receive a hard copy of the annual report or Form 20F free of charge upon request by e-mail to celp@novonordisk.com. When e-mailing, please state the exact mailing address and the document(s) you wish to receive. | ENG |
